Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
20.05
-5.01 (-19.99%)
Aug 7, 2025, 3:56 PM EDT
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 290.01B JPY in the quarter ending June 30, 2025, a decrease of -8.20%. This brings the company's revenue in the last twelve months to 1.20T, up 10.29% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.
Revenue (ttm)
1,196.22B JPY
Revenue Growth
+10.29%
P/S Ratio
9.96
Revenue / Employee
238.01M JPY
Employees
5,026
Market Cap
82.61B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,170.61B | 59.24B | 5.33% |
| Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
| Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Chugai Pharmaceutical News
- 14 days ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 14 days ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha
- 2 months ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times
- 4 months ago - Japanese Stocks Close Lower Amid Global Trade Tensions - Barron's
- 6 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Chugai Pharmaceutical Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript - GuruFocus